{
    "id": "85dda33f-0bbd-4beb-887b-a67e5b361e9b",
    "relatedPaper": 0,
    "context": {
        "metadata": {
            "titleEn": "Cancer and heat - iron - death chemotherapy treatment comparison of RNA - seq data together",
            "titleCn": "癌症光热-铁死亡-化疗协同治疗比较的RNA-seq数据",
            "description": "Ferroptosis is the recent discovery of programmed cell death, the outbreak of ferrous ions by the cell and the subsequent Fenton reaction.Due to the strict control of iron metabolism, iron sources in the tumor cells is limited.Due to death of cancer treatment in the iron rarely considered in layered structure, multi-layer Fe2O3 structure (UF @ PPDF NPs) is through modulation super-small gamma Fe2O3 nanometer crystal components, and further combining with cancer targeted folic acid (FA), chemotherapy drugs more soft than star (Banks).Hierarchical assembly of gamma Fe2O3 nanocrystalline help switchable magnetic resonance imaging (MRI), greatly improving the efficiency of iron death and very high secondary near infrared (NIR) II solar-thermal conversion.For MRI, UF @ PPDF nanoparticles (NPs) can be clearly demonstrate a compact size and degree, and has a dynamic T2 and T1 imaging switch.UF @ PPDF NPs in NIR - II show the effective therapy of field under irradiation (PTT), and iron ion and Dox controlled release, so as to realize the PTT - - iron death three functional collaborative cancer chemotherapy treatment, used for tumor ablation.Differentially expressed genes of RNA sequencing analysis shows that this treatment has many aspects of role in signal transduction in cancer cells.Cell respiration and electron transfer significantly increases, while including modification of chromatin and RNA transcription activity of epigenetic way was badly cut, with the overall impact of apoptosis.Therefore, gamma Fe2O3 structure provides a new possibility for efficient deep tumor treatment.HeLa in PBS and UF @ PPDF NPs and NIR - II 1064 nm laser irradiation (1.1 W cm - 2, and 10 minutes).After the cells 2 hours continuous culture for RNA sequencing.Quality control data quality, data using Trimmomatics v0.38 pretreatment.Then use the HISAT v2.1.0 readings than to hg38 genome.FPKM calculated by Rsubread and edgeR.Enrichment factor change and p values by quantitative edgeR and negative binomial model.",
            "descriptionCn": "Ferroptosis 是最近发现的程序性细胞死亡，由细胞亚铁离子爆发和随后的 Fenton 反应引起。 由于严格控制铁代谢，肿瘤细胞中的铁源是有限的。 由于在铁死亡癌症治疗中很少考虑分层铁结构，多层 Fe2O3 结构 (UF@PPDF NPs) 是通过调制超小 γ-Fe2O3 纳米晶体组件，并进一步结合癌细胞靶向叶酸 (FA)、化疗药物多柔比星 ( 多克斯）。 分层组装的 γ-Fe2O3 纳米晶体有助于可切换的磁共振成像 (MRI)、大大提高的铁死亡效率和非常高的二次近红外 (NIR-II) 光热转换。 对于 MRI，UF@PPDF 纳米粒子 (NPs) 可以在尺寸和紧凑度方面清晰地显示组织，并具有动态 T2-T1 成像切换。 UF@PPDF NPs 在 NIR-II 照射下表现出高效的光热疗法 (PTT)，以及铁离子和 Dox 的受控释放，从而实现 PTT-化疗-铁死亡三功能协同癌症治疗，用于肿瘤消融。 差异表达基因的 RNA 测序分析表明这种疗法在癌细胞信号传导中具有多方面的作用。 细胞呼吸和电子传递显着上调，而包括染色质修饰和 RNA 转录活性在内的表观遗传途径被严重下调，具有细胞凋亡的总体影响。 因此，γ-Fe2O3 结构为高效深部肿瘤治疗提供了新的可能性。将HeLa细胞用PBS和UF@PPDF NPs和 NIR-II 1064 nm激光照射(1.1 W cm−2, 10 分钟)。之后，将细胞连续培养2小时用于RNA 测序。数据质量进行质控，数据使用 Trimmomatics v0.38 进行了预处理。然后使用 HISAT v2.1.0将读数比对到hg38基因组。FPKM由Rsubread和edgeR计算得出。富集倍数变化和p值由edgeR及其负二项式模型量化。 ",
            "instructions": "C-U-cleandata;",
            "instructionsCn": "RNA-seq fastaQ cleandata；\nC-U-cleandata",
            "east": 0.0,
            "west": 0.0,
            "south": 0.0,
            "north": 0.0,
            "startTime": "2019-01-02 11:33:14",
            "endTime": "2020-02-01 11:33:14",
            "fileSize": 22743980544.0,
            "cstr": "18406.11.HumanNat.tpdc.300246",
            "doi": "10.11888/HumanNat.tpdc.300246",
            "dataFormat": null,
            "license": "4"
        },
        "authorList": [
            {
                "nameCn": "秦燕",
                "nameEn": "QIN Yan",
                "unitEn": "",
                "unitCn": "中国科学院生物物理研究所"
            }
        ],
        "literatureList": [
            {
                "titleCn": null,
                "titleEn": "Modulated ultrasmall γ-Fe2O3 nanocrystal assembles for switchable magnetic resonance imaging and photothermal-ferroptotic-chemical synergistic cancer therapy",
                "referenceCn": null,
                "referenceEn": "Yang, B., Zhang, Y., Sun, L., Wang, J., Zhao, Z., Huang, Z., Mao, W., Xue, R., Chen, R., Luo, J.#, Wang, T.#, Jiang, J.#, and Qin, Y.# (2022). Modulated Ultrasmall γ-Fe2O3 Nanocrystal Assembles for Switchable Magnetic Resonance Imaging and Photothermal-Ferroptotic-Chemical Synergistic Cancer Therapy. Advanced Functional Materials."
            }
        ],
        "keywordStandList": [
            {
                "nameCn": "人地关系",
                "nameEn": "Human-nature Relationship"
            }
        ],
        "themeList": [
            {
                "nameCn": "微生物资源",
                "nameEn": "Microbial resources"
            },
            {
                "nameCn": "生物资源",
                "nameEn": "Biological Resources"
            }
        ],
        "placeKeywordList": [
            {
                "keywordCn": "无",
                "keywordEn": "None"
            }
        ],
        "temporalKeywordList": [
            {
                "keywordCn": "无",
                "keywordEn": "None",
                "type": "temporal"
            }
        ],
        "fundVOList": [
            {
                "titleCn": "非编码RNA及其新型修饰在翻译水平精密调控干细胞多能性的研究",
                "titleEn": "Non-coding RNAs and their novel modifications precisely regulate stem cell pluripotency at the translational level"
            }
        ],
        "projectList": [
            {
                "titleCn": "国家青藏高原科学数据中心",
                "titleEn": "National Tibetan Plateau / Third Pole Environment Data Center"
            }
        ],
        "relatedDataList": [
            {
                "titleCn": "祁连山重点区域30m人类活动参数产品数据集（V1.0）",
                "titleEn": "Human activity parameters in Qilian Mountain area (V1.0)"
            },
            {
                "titleCn": "青藏高原1:100万行政边界数据（2017）",
                "titleEn": "Administrative boundaries data at 1:1000 000 scale over the Tibetan Plateau (2017)"
            },
            {
                "titleCn": "祁连山重点区域人类活动数据集 (2018)",
                "titleEn": "The human activity dataset in key area of Qilian Mountaion (2018)"
            },
            {
                "titleCn": "三极人口&GDP数据集（1970-2006）",
                "titleEn": "Three-pole population &GDP dataset (1970-2006)"
            },
            {
                "titleCn": "祁连山区域30m人类活动参数产品数据集（V1.0）（2018）",
                "titleEn": "Human activity parameters at Qilian Mountain Area (V1.0) (2018)"
            },
            {
                "titleCn": "祁连山区域30m人类活动参数产品数据集（V1.0）（1985-2017）",
                "titleEn": "Human activity parameters at Qilian Mountain Area (V1.0) (1985-2017)"
            },
            {
                "titleCn": "耦合模式比较计划第6阶段CNRM-CM6-1模式全球植被生产力月数据（1850-2014）",
                "titleEn": "Global vegetation productivity monthly data obtained by CNRM-CM6-1 mode of CMIP6 (1850-2014)"
            },
            {
                "titleCn": "青藏高原300米分辨率土壤侵蚀（水蚀）强度数据集（1992、2005、2015）",
                "titleEn": "Dataset of Soil  Erosion （water) Intensity with 300m resoluton in Tibetan Plateau (1992, 2005, 2015)"
            },
            {
                "titleCn": "可可西里-土地覆盖及植被类型地面验证点数据集",
                "titleEn": "Hoh Xil - land cover and vegetation type ground verification point dataset"
            },
            {
                "titleCn": "黄河源区-土地覆盖及植被类型地面验证点数据集",
                "titleEn": "Source region of Yellow River - land cover and vegetation type ground verification point dataset"
            }
        ]
    },
    "extract_pdfs_data": null,
    "query": {
        "Example": [
            {
                "QuestionEn": "Can you provide an example of a data collection method used to analyze the synergistic effects of photothermal therapy, ferroptosis, and chemotherapy on cancer cells using RNA-seq?",
                "QuestionCn": "您能否提供一个数据收集方法的示例，用于分析光热疗法、铁死亡和化疗对癌细胞的协同效应，使用RNA-seq？",
                "AnswerEn": "A data collection method involves treating HeLa cells with PBS and UF@PPDF NPs followed by NIR-II 1064 nm laser irradiation. After treatment, the cells are continuously cultured for 2 hours before RNA sequencing. The data undergoes quality control, preprocessing with Trimmomatics v0.38, and alignment to the hg38 genome using HISAT v2.1.0. FPKM is calculated with Rsubread and edgeR, and enrichment fold changes and p-values are quantified using edgeR's negative binomial model.",
                "AnswerCn": "一种数据收集方法涉及用PBS和UF@PPDF纳米颗粒处理HeLa细胞，然后进行NIR-II 1064 nm激光照射。处理后，细胞持续培养2小时，然后进行RNA测序。数据经过质量控制，使用Trimmomatics v0.38进行预处理，并使用HISAT v2.1.0对hg38基因组进行比对。使用Rsubread和edgeR计算FPKM，并使用edgeR的负二项模型量化富集倍数变化和p值。",
                "Level": "C2(Understanding)"
            }
        ],
        "Feature Specification": [
            {
                "QuestionEn": "What are the specific features and characteristics of RNA-seq data collection methods used in comparing photothermal- and ferroptosis-chemo synergistic cancer therapies?",
                "QuestionCn": "在比较光热-和铁死亡-化疗协同癌症治疗中使用的RNA-seq数据收集方法的具体特征和特点是什么？",
                "AnswerEn": "HeLa cells, PBS treatment, UF@PPDF NPs, NIR-II 1064 nm laser irradiation, 2-hour culture, Trimmomatics v0.38, hg38 genome, HISAT v2.1.0, FPKM values, Rsubread, edgeR, enrichment fold changes, p-values, edgeR's negative binomial model",
                "AnswerCn": "HeLa细胞，PBS处理，UF@PPDF纳米颗粒，NIR-II 1064 nm激光照射，2小时培养，Trimmomatics v0.38，hg38基因组，HISAT v2.1.0，FPKM值，Rsubread，edgeR，富集倍数变化，p值，edgeR的负二项模型。",
                "Level": "C4(Analyzing)"
            }
        ],
        "Quantification": [
            {
                "QuestionEn": "How many differential expression gene measurements were obtained from RNA sequencing in a dataset assessing ferroptosis-related cancer therapy?",
                "QuestionCn": "在评估与铁死亡相关的癌症治疗的数据集中，从RNA测序中获得了多少个差异表达基因测量值？",
                "AnswerEn": "The original answer does not provide a specific numerical value for the number of differential expression gene measurements obtained from RNA sequencing. Therefore, no refined answer can be extracted based on the given instructions.",
                "AnswerCn": "原始答案未提供从RNA测序中获得的差异表达基因测量的具体数值。因此，无法根据给定指示提取出更精确的答案。",
                "Level": "C1(Remembering)"
            }
        ],
        "Definition": [
            {
                "QuestionEn": "What does 'differential expression analysis' mean in the context of RNA-seq data?",
                "QuestionCn": "在RNA-seq数据的背景下，“差异表达分析”指的是比较不同条件下基因表达水平的变化，以识别在不同实验组或处理组之间显著上调或下调的基因。",
                "AnswerEn": "Differential expression analysis in the context of RNA-seq data refers to the process of identifying genes that show statistically significant differences in expression levels between different conditions or treatments. In this field, it involves using RNA sequencing to compare gene expression in HeLa cells treated with UF@PPDF nanoparticles and NIR-II laser irradiation versus those treated with PBS, quantifying changes in gene expression using methods like edgeR and its negative binomial model to analyze fold changes and p-values.",
                "AnswerCn": "差异表达分析在RNA-seq数据的背景下是指识别在不同条件或处理之间表现出统计显著性差异的基因的过程。在这一领域，它涉及使用RNA测序比较用UF@PPDF纳米颗粒和NIR-II激光照射处理的HeLa细胞与用PBS处理的细胞的基因表达，利用如edgeR等方法和其负二项模型来分析倍数变化和p值，从而量化基因表达的变化。",
                "Level": "C2(Understanding)"
            }
        ],
        "Interpretation": [
            {
                "QuestionEn": "How can the combination of RNA sequencing and differential gene expression analysis provide insights into the mechanisms of ferroptosis and its role in multimodal cancer therapies?",
                "QuestionCn": "RNA测序和差异基因表达分析的结合如何提供对铁死亡机制及其在多模式癌症治疗中的作用的洞察。",
                "AnswerEn": "RNA sequencing and differential gene expression analysis can reveal the transcriptional changes in cancer cells subjected to treatments such as photothermal therapy, chemotherapy, and ferroptosis. By comparing gene expression profiles before and after treatment, researchers can infer which pathways are upregulated or downregulated, providing insights into how these treatments interact at the molecular level. In this context, it was observed that cell respiration and electron transport were significantly upregulated, while epigenetic pathways like chromatin modification and RNA transcription activity were downregulated, indicating a complex interaction affecting cell apoptosis.",
                "AnswerCn": "RNA测序和差异基因表达分析可以揭示癌细胞在接受光热疗法、化疗和铁死亡等治疗后转录水平的变化。通过比较治疗前后的基因表达谱，研究人员可以推断出哪些通路被上调或下调，从而提供对这些治疗在分子水平上相互作用的见解。在这种情况下，观察到细胞呼吸和电子传递显著上调，而表观遗传通路如染色质修饰和RNA转录活性则下调，表明影响细胞凋亡的复杂相互作用。",
                "Level": "C6(Creating)"
            }
        ],
        "Causal Antecedent": [
            {
                "QuestionEn": "What factors contribute to the complexity of data collection in RNA-seq studies when comparing photothermal-iron death-chemotherapy synergistic treatments in cancer?",
                "QuestionCn": "在比较光热-铁死亡-化疗协同治疗癌症的RNA-seq研究中，数据收集复杂性的因素包括哪些？",
                "AnswerEn": "The complexity arises from the need to integrate multiple therapeutic modalities, such as photothermal therapy, iron-induced cell death, and chemotherapy, which involve diverse biological processes. The presence of layered Fe2O3 structures in nanoparticles and their dynamic behavior under NIR-II irradiation add further complexity. Additionally, the requirement for precise control and synchronization of nanoparticle-mediated drug delivery, magnetic resonance imaging, and gene expression analysis, using tools like Trimmomatics, HISAT, and edgeR, contribute to the intricacy of the data collection process. This involves handling the challenges of differentially expressed gene analysis, ensuring high-quality RNA sequencing data, and accurately aligning reads to the human genome for effective quantification of gene activity changes.",
                "AnswerCn": "复杂性源于需要整合多种治疗方式，如光热疗法、铁诱导的细胞死亡和化疗，这些方式涉及多种生物过程。纳米颗粒中层状Fe2O3结构的存在及其在NIR-II照射下的动态行为进一步增加了复杂性。此外，精确控制和同步纳米颗粒介导的药物递送、磁共振成像和基因表达分析的需求，使用如Trimmomatics、HISAT和edgeR等工具，增加了数据收集过程的复杂性。这涉及处理差异表达基因分析的挑战，确保高质量的RNA测序数据，并准确将读取序列比对到人类基因组，以有效量化基因活性变化。",
                "Level": "C4(Analyzing)"
            }
        ],
        "Causal Consequence": [
            {
                "QuestionEn": "What are the consequences of using layered Fe2O3 structures combined with folic acid and doxorubicin for RNA-seq data collection on cancer cell treatment methodologies?",
                "QuestionCn": "使用分层Fe2O3结构结合叶酸和多柔比星进行RNA-seq数据收集对癌症细胞治疗方法的影响是什么？",
                "AnswerEn": "The use of layered Fe2O3 structures combined with folic acid and doxorubicin allows for a multi-functional approach to cancer treatment, improving magnetic resonance imaging, enhancing ferroptosis efficiency, and enabling high photothermal conversion under NIR-II irradiation. This results in a comprehensive RNA-seq dataset showcasing the impacts on cancer cell signaling, including upregulation of cell respiration and electron transport, as well as downregulation of epigenetic pathways related to chromatin modification and RNA transcription, indicating an overall apoptotic effect.",
                "AnswerCn": "使用分层的Fe2O3结构结合叶酸和多柔比星，能够实现多功能的癌症治疗方法，改善磁共振成像，增强铁死亡效率，并在近红外-II辐射下实现高光热转化。这导致了一个全面的RNA-seq数据集，展示了对癌细胞信号传导的影响，包括细胞呼吸和电子传输的上调，以及与染色质修饰和RNA转录相关的表观遗传途径的下调，表明整体上具有促凋亡效果。",
                "Level": "C4(Analyzing)"
            }
        ],
        "Instrumental/Procedural": [
            {
                "QuestionEn": "What procedural steps can be undertaken to ensure the controlled release of iron ions and chemotherapy drugs in a dataset focusing on synergistic cancer therapies using RNA-seq data?",
                "QuestionCn": "可以采取哪些程序步骤来确保在一个专注于协同癌症疗法的RNA-seq数据集中控制释放铁离子和化疗药物？",
                "AnswerEn": "In a dataset exploring synergistic cancer therapies, controlled release of iron ions and chemotherapy drugs can be achieved through the use of layered Fe2O3 structures (UF@PPDF NPs) that are modulated with ultra-small γ-Fe2O3 nanocrystal components. This is further complemented by targeting cancer cells with folic acid and incorporating the chemotherapy drug Doxorubicin. Efficient photothermal therapy (PTT) is ensured under NIR-II irradiation, resulting in precise control over ion and drug release, thus enabling PTT-chemotherapy-ferroptosis tri-functional synergistic cancer treatment. The procedural steps involve irradiation with NIR-II 1064 nm laser (1.1 W cm−2, 10 minutes) and subsequent RNA sequencing to analyze differential gene expression, with quality control and preprocessing using tools like Trimmomatics v0.38, HISAT v2.1.0 for genome alignment, and FPKM calculations through Rsubread and edgeR.",
                "AnswerCn": "在一个探索协同癌症治疗的数据集中，通过使用分层的Fe2O3结构（UF@PPDF NPs）来实现铁离子和化疗药物的控制释放，这些结构通过超小的γ-Fe2O3纳米晶体组件进行调节。该方法进一步通过叶酸靶向癌细胞，并结合化疗药物多柔比星（Doxorubicin）。在近红外-II（NIR-II）照射下，确保了高效的光热治疗（PTT），从而精确控制离子和药物的释放，使得PTT-化疗-铁死亡的三重功能协同癌症治疗成为可能。程序步骤包括使用1064 nm的NIR-II激光（1.1 W cm−2，10分钟）进行照射，随后进行RNA测序以分析差异基因表达，质量控制和预处理使用工具如Trimmomatics v0.38、HISAT v2.1.0进行基因组比对，以及通过Rsubread和edgeR进行FPKM计算。",
                "Level": "C3(Applying)"
            }
        ]
    }
}